Taylor & Francis Group
Browse
1/1
2 files

Epigenetic association analysis of clinical sub-phenotypes in patients with polycystic ovary syndrome (PCOS)

dataset
posted on 2019-02-20, 07:25 authored by Vibe Maria Jacobsen, Shuxia Li, Ancong Wang, Dongyi Zhu, Min Liu, Mads Thomassen, Torben Kruse, Qihua Tan

Polycystic ovarian syndrome (PCOS) is a complex disorder affecting up to 15–20% of reproductive women. PCOS has recently been investigated using genome-wide association studies revealing important mutations and DNA methylation sites associated with the syndrome. As a clinically highly heterogenous condition, studying the molecular basis of the differential manifestation of PCOS is both meaningful concerning individualized management and important for understanding the biology of PCOS. Using genome-wide DNA methylation data collected from PCOS patients, we performed a powerful region-based analysis to detect differentially methylated regions (DMR) by correlating DNA methylation pattern in a genomic region with the level of each PCOS clinical sub-phenotype. We identified seven significant DMRs on chromosome 19 (12877188-12876846 bp) and chromosome 6 (MHC region) associated with prolactin level, as well as chromosomes 11 and 2 associated with metabolic attributes. Functional annotation linked significant DNA methylation patterns to functional genes (HOOK2, BDNFl, HLA-G, HLA-H, HLA-J, RNF39, etc) of metabolic disorders and immunity or novel associations to serve as targets for validation and replication.

Funding

This work was jointly supported by the Region of Southern Denmark 2012 research grant project no. 12/6629, the Novo Nordisk Foundation Medical and Natural Sciences Research Grant NNF13OC0007493 and by the Shandong Provincial Natural Science Foundation in China (grant no. ZR2014HP026).

History